Immediate Impact
1 by Nobel laureates 18 hit
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Hit
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
2022 Hit
Works of Cyril Konto being referenced
A Phase 1, First-in-Human, Dose Escalation and Dose-Expansion Study of a BCMAxCD38xCD3 Targeting Trispecific Antibody ISB 2001 in Subjects with Relapsed/Refractory Multiple Myeloma
2023
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
2014